how are glp 1 drugs administered GLP-1 Medications: Everything You Need to Know Designing GLP-1 delivery: structural perspectives
Description
According to a report from the WHO, in 2022, ~830 million people worldwide had diabetes, and over 95% of diabetes cases are type 2
We selected appropriate confounders, such as index year, sex, age, diabetes duration, health screening variables, comorbidities, and antidiabetic drugs, for PS matching to minimize the influence of factors other than GLP-1 RA exposure
Table 3 summarizes RCTs of the dual and triple GLP1-RA use in obesity
R., & Piper, B
GLP-1Ra at doses intended for T2D management Studies have examined the risk of fracture in both obese and non-obese individuals taking GLP-1Ra at doses intended for T2D (such as liraglutide 1.2 mg daily versus 3.0 mg daily for obesity) [75,76,77]
